In adolescents with residual traumatic brain injury symptoms, positive brain functional dynamics occurred in 77% with Cerebrolysin versus 50% with piracetam and magne-B6.
In plain wordsIn adolescents with residual brain injury symptoms, positive brain functional changes occurred in 77% with Cerebrolysin versus 50% with piracetam and magne-B6.
- Peptide
- Cerebrolysin
- Outcome
- IncreasePositive brain functional dynamics
- Study
n = 76
- Comparator
- Piracetam and magne-B6
- Outcome group
- Neuroprotection · Nervous system and cognition
- Studied dose
- Dose not stated · one monthAs given in this study (human).
Measurements
- Patients with positive brain functional dynamics
- 77%
- Cerebrolysin, after the one-month nootropic therapy
- Patients with positive brain functional dynamics
- 50%
- Piracetam and magne-B6, after the one-month nootropic therapy
Source sentences
After the end of the nootropic therapy, 77% of patients treated with cerebrolysin as well as 50% of patients treated with piracetam and magne-B6 have demonstrated the positive dynamics of their brain functional state
2 context sentences(design, population, supporting numbers)
The study included 76 adolescents, aged 12-18 years, who have undergone severe closed head trauma with brain commotion 1/2--5 years ago.
Patients have been divided into 3 groups treated during one month with cerebrolysin, piracetam or magne-B6, respectively.